{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:55:09Z","timestamp":1794542109301,"version":"4.9.1"},"reference-count":54,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"12","license":[{"start":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T00:00:00Z","timestamp":1683158400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and its superantigen MID\/hag, associated with extralong CDR3 and HLA-DRB1*04 or HLADRB1* 07 haplotype. The aim of the present study was to extend the antigen screening to further bacteria and viruses. The fragment antibody-binding (Fab) regions of seven new and 15 previously reported cases were analyzed. The reactivity of non-Moraxella spp.-reactive Fab regions against lysates of Rothia mucilaginosa was observed in 5\/22 (22.7%) cases. Galactofuranosyl transferase (Gltf) and 2,3-butanediol dehydrogenase (Bdh) of R. mucilaginosa were identified by comparative silver- and immuno-staining in two-dimensional gels, with subsequent mass spectrometry and validation by western blots and enzyme-linked immunosorbent assay. Both R. mucilaginosa Gltf and Bdh induced BCR pathway activation and proliferation in vitro. Apoptosis was induced by recombinant Gltf\/ETA\u2019-immunotoxin conjugates in DEV cells expressing recombinant R. mucilaginosa-reactive BCR. Reactivity against M. catarrhalis RpoC was confirmed in 3\/7 newly expressed BCR (total 10\/22 reactive to Moraxella spp.), resulting in 15\/22 (68.2%) cases with BCR reactivity against defined bacterial antigens. These findings strengthen the hypothesis of bacterial trigger contributing to subsets of NLPHL.<\/jats:p>","DOI":"10.3324\/haematol.2023.282698","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T02:54:48Z","timestamp":1683168888000},"page":"3347-3358","source":"Crossref","is-referenced-by-count":20,"title":["B-cell receptor reactivity against &lt;i&gt;Rothia mucilaginosa&lt;\/i&gt; in nodular lymphocyte-predominant Hodgkin lymphoma"],"prefix":"10.3324","volume":"108","author":[{"given":"Lorenz","family":"Thurner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Fadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Regitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Age","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Mauro","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer Maria","family":"Bohle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Vornanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"De Leval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tiacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Borchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Poeschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva C.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Dieter","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hoth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"K\u00fcppers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karola","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Leo","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren L.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Bewarder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,5,4]]},"reference":[{"key":"55018","doi-asserted-by":"crossref","unstructured":"Saarinen S, Pukkala E, Vahteristo P, M\u00e4kinen MJ, Franssila K, Aaltonen LA. High familial risk in nodular lymphocyte-predominant Hodgkin lymphoma. J Clin Oncol. 2013; 31(7):938-943.","DOI":"10.1200\/JCO.2012.43.5958"},{"key":"55019","doi-asserted-by":"crossref","unstructured":"Brune V, Tiacci E, Pfeil I. Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med. 2008; 205(10):2251-2268.","DOI":"10.1084\/jem.20080809"},{"key":"55020","doi-asserted-by":"crossref","unstructured":"Hartmann S, Doring C, Jakobus C. Nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?. PLoS One. 2013; 8(11):e78812.","DOI":"10.1371\/journal.pone.0078812"},{"key":"55021","doi-asserted-by":"crossref","unstructured":"Jackson H, Parker F., Hodgkin\u2019s disease. II. Pathology. N Engl J Med. 1944; 231:35-44.","DOI":"10.1056\/NEJM194407132310201"},{"key":"55022","unstructured":"Anagnostopoulos I, Hansmann ML, Franssila K. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 2000; 96(5):1889-1899."},{"key":"55023","doi-asserted-by":"crossref","unstructured":"Hartmann S, Schuhmacher B, Rausch T. Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma. Leukemia. 2015; 40(9):2278-2285.","DOI":"10.1038\/leu.2015.328"},{"key":"55024","doi-asserted-by":"crossref","unstructured":"Kuppers R, Rajewsky K, Braeuninger A, Hansmann ML. L&amp;H cells in lymphocyte-predominant Hodgkin\u2019s disease. N Engl J Med. 1998; 338(11):763-764.","DOI":"10.1056\/NEJM199803123381113"},{"key":"55025","doi-asserted-by":"crossref","unstructured":"Marafioti T, Hummel M, Anagnostopoulos I. Origin of nodular lymphocyte-predominant Hodgkin\u2019s disease from a clonal expansion of highly mutated germinal-center B cells. N Engl J Med. 1997; 337(7):453-458.","DOI":"10.1056\/NEJM199708143370703"},{"key":"55026","doi-asserted-by":"crossref","unstructured":"Wlodarska I, Nooyen P, Maes B. Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood. 2003; 101(2):706-710.","DOI":"10.1182\/blood-2002-05-1592"},{"key":"55027","doi-asserted-by":"crossref","unstructured":"Mottok A, Renn\u00e9 C, Willenbrock K, Hansmann ML, Br\u00e4uninger A. Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood. 2007; 110(9):3387-3390.","DOI":"10.1182\/blood-2007-03-082511"},{"key":"55028","doi-asserted-by":"crossref","unstructured":"Braeuninger A, Kuppers R, Strickler JG, Wacker HH, Rajewsky K, Hansmann ML. Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc Natl Acad Sci U S A. 1997; 94(17):9337-9342.","DOI":"10.1073\/pnas.94.17.9337"},{"key":"55029","doi-asserted-by":"crossref","unstructured":"Falini B, Bigerna B, Pasqualucci L. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin\u2019s disease. Blood. 1996; 87(2):465-471.","DOI":"10.1182\/blood.V87.2.465.bloodjournal872465"},{"key":"55030","doi-asserted-by":"crossref","unstructured":"Greiner A, Tobollik S, Buettner M. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J Pathol. 2005; 205(5):541-547.","DOI":"10.1002\/path.1746"},{"key":"55031","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Sankaranand VS, Anant S. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem. 1999; 274(26):18470-18476.","DOI":"10.1074\/jbc.274.26.18470"},{"key":"55032","doi-asserted-by":"crossref","unstructured":"Fan Z, Natkunam Y, Bair E, Tibshirani R, Warnke RA. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol. 2003; 27(10):1346-1356.","DOI":"10.1097\/00000478-200310000-00007"},{"key":"55033","doi-asserted-by":"crossref","unstructured":"Campo E, Jaffe ES, Cook JR. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022; 140(11):1229-1253.","DOI":"10.1182\/blood.2022015851"},{"key":"55034","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia. 2022; 36(7):1720-1748.","DOI":"10.1038\/s41375-022-01625-x"},{"key":"55035","doi-asserted-by":"crossref","unstructured":"Schumacher MA, Schmitz R, Brune V. Mutations in the genes coding for the NF-kappaB regulating factors IkappaBalpha and A20 are uncommon in nodular lymphocytepredominant Hodgkin\u2019s lymphoma. Haematologica. 2010; 95(1):153-157.","DOI":"10.3324\/haematol.2009.010157"},{"key":"55036","doi-asserted-by":"crossref","unstructured":"Bein J, Thurner L, Hansmann ML, Hartmann S. Lymphocyte predominant cells of nodular lymphocyte predominant Hodgkin lymphoma interact with rosetting T cells in an immunological synapse. Am J Hematol. 2020; 95(12):1495-1502.","DOI":"10.1002\/ajh.25972"},{"key":"55037","doi-asserted-by":"crossref","unstructured":"Prakash S, Fountaine T, Raffeld M, Jaffe ES, Pittaluga S. IgD positive L&amp;H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol. 2006; 30(5):585-592.","DOI":"10.1097\/01.pas.0000194741.87798.45"},{"key":"55038","unstructured":"Thurner L, Kemele M, Regitz E. Moraxella catarrhalis-a bacterial involvement in the origin of nodular lymphocyte predominant Hodgkin lymphoma of IGD type?. Haematologica. 2015; 100(s1):106-107."},{"key":"55039","doi-asserted-by":"crossref","unstructured":"Thurner L, Hartmann S, Fadle N. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nat Commun. 2020; 11(1):2465.","DOI":"10.1038\/s41467-020-16375-6"},{"key":"55040","doi-asserted-by":"crossref","unstructured":"Paschold L, Willscher E, Bein J. Evolutionary clonal trajectories in nodular lymphocyte-predominant Hodgkin lymphoma with high risk of transformation. Haematologica. 2021; 106(10):2654-2666.","DOI":"10.3324\/haematol.2021.278427"},{"key":"55041","doi-asserted-by":"crossref","unstructured":"Behringer K, Goergen H, Hitz F. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin\u2019s lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. Lancet. 2015; 385(9976):1418-1427.","DOI":"10.1016\/S0140-6736(14)61469-0"},{"key":"55042","doi-asserted-by":"crossref","unstructured":"Engert A, Borchmann P, Pluetschow A. Dose-escalation with BEACOPP escalated is superior to ABVD in the combinedmodality treatment of early unfavorable Hodgkin lymphoma: final analysis of the German Hodgkin Study Group (GHSG) HD14 trial. Blood. 2010; 116(21):765.","DOI":"10.1182\/blood.V116.21.765.765"},{"key":"55043","doi-asserted-by":"crossref","unstructured":"Borchmann P, Goergen H, Kobe C. EBEACOPP with or without rituximab in interim-PET-positive advanced-stage Hodgkin lymphoma: updated results of the international, randomized phase 3 GHSG HD18 trial. Hematol Oncol. 2017; 35(S2):65.","DOI":"10.1002\/hon.2437_52"},{"key":"55044","doi-asserted-by":"crossref","unstructured":"Borchmann P, Goergen H, Kobe C. PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet. 2017; 390(10114):2790-2802.","DOI":"10.1016\/S0140-6736(17)32134-7"},{"key":"55045","doi-asserted-by":"crossref","unstructured":"Pfreundschuh M, Schubert J, Ziepert M. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008; 9(2):105-116.","DOI":"10.1016\/S1470-2045(08)70002-0"},{"key":"55046","doi-asserted-by":"crossref","unstructured":"Schmitz N, Nickelsen M, Ziepert M. Conventional chemoimmunotherapy (R-CHOEP-14) or high-dose therapy (R-Mega-CHOEP) for young, high-risk patients with aggressive B-cell lymphoma: final results of the randomized Mega-CHOEP trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). J Clin Oncol. 2011; 29(15_suppl):8002.","DOI":"10.1200\/jco.2011.29.15_suppl.8002"},{"key":"55047","doi-asserted-by":"crossref","unstructured":"Pfreundschuh M, Murawski N, Ziepert M. Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: results of the 2x2 randomized UNFOLDER trial of the DSHNHL\/GLA. J Clin Oncol. 2018; 36(15_suppl):7574.","DOI":"10.1200\/JCO.2018.36.15_suppl.7574"},{"key":"55048","doi-asserted-by":"crossref","unstructured":"Poeschel V, Held G, Ziepert M. Excellent outcome of young patients (18-60 years) with favourable-prognosis diffuse large B-cell lymphoma (DLBCL) treated with 4 cycles CHOP plus 6 applications of rituximab: results of the 592 patients of the Flyer trial of the DSHNHL\/GLA. Blood. 2018; 132(Suppl 1):781.","DOI":"10.1182\/blood-2018-99-112403"},{"key":"55049","doi-asserted-by":"crossref","unstructured":"Kuppers R, Schneider M, Hansmann ML. Laser-based microdissection of single cells from tissue sections and PCR analysis of rearranged immunoglobulin genes from isolated normal and malignant human B cells. Methods Mol Biol. 2013; 971:49-63.","DOI":"10.1007\/978-1-62703-269-8_3"},{"key":"55050","unstructured":"Voswinkel J, Kerkdijk AJ, Mueller A, Assmann G, Pfreundschuh M, Held G. A novel system to test for specificity of B cell receptors from tissue of Wegener\u2019s granulomatosis patients. Clin Exp Rheumatol. 2008; 26(3 Suppl 49):S90-S96."},{"key":"55051","doi-asserted-by":"crossref","unstructured":"de Haard HJ, van NN Reurs A. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J Biol Chem. 1999; 274(26):18218-18230.","DOI":"10.1074\/jbc.274.26.18218"},{"key":"55052","doi-asserted-by":"crossref","unstructured":"Zwick C, Fadle N, Regitz E. Autoantigenic targets of B-cell receptors derived from chronic lymphocytic leukemias bind to and induce proliferation of leukemic cells. Blood. 2013; 121(23):4708-4717.","DOI":"10.1182\/blood-2012-08-447904"},{"key":"55053","doi-asserted-by":"crossref","unstructured":"Thurner L, Nimmesgern A, Neumann F. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting. Leukemia. 2019; 33(1):148-158.","DOI":"10.1038\/s41375-018-0182-1"},{"key":"55054","doi-asserted-by":"crossref","unstructured":"Thurner L, Preuss K-D, Bewarder M. Hyper N-glycosylated SAMD14 and neurabin-I as driver CNS autoantigens of PCNSL. Blood. 2018; 132(26):2744-2753.","DOI":"10.1182\/blood-2018-03-836932"},{"key":"55055","doi-asserted-by":"crossref","unstructured":"Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat Rev Cancer. 2005; 5(4):251-262.","DOI":"10.1038\/nrc1589"},{"key":"55056","doi-asserted-by":"crossref","unstructured":"Thurner L, Hartmann S, Bewarder M. Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma. Haematologica. 2021; 106(8):2224-2232.","DOI":"10.3324\/haematol.2019.241653"},{"key":"55057","doi-asserted-by":"crossref","unstructured":"Thurner L, Hartmann S, Fadle N. LRPAP1 is a frequent proliferation-inducing antigen of BCRs of mantle cell lymphomas and can be used for specific therapeutic targeting. Leukemia. 2019; 33(1):148-158.","DOI":"10.1038\/s41375-018-0182-1"},{"key":"55058","doi-asserted-by":"crossref","unstructured":"Thurner L, Fadle N, Bittenbring JT. LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome. Blood. 2021; 137(23):3251-3258.","DOI":"10.1182\/blood.2020008835"},{"key":"55059","doi-asserted-by":"crossref","unstructured":"Hartmann S, D\u00f6ring C, Jakobus C. Nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma - endpoints of a spectrum of one disease?. PLoS One. 2013; 8(11):e78812.","DOI":"10.1371\/journal.pone.0078812"},{"key":"55060","doi-asserted-by":"crossref","unstructured":"Hartmann S, D\u00f6ring C, Vucic E. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell\/histiocyte rich large B cell lymphoma. Br J Haematol. 2015; 169(3):415-422.","DOI":"10.1111\/bjh.13310"},{"key":"55061","doi-asserted-by":"crossref","unstructured":"Masters BR. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases, Eighth Edition (2015) Eds: John E. Bennett, Raphael Dolin, Martin J. Blaser. ISBN: 13-978-1-4557-4801-3, Elsevier Saunders. Graefes Arch Clin Exp Ophthalmol. 2016; 254:2285-2287.","DOI":"10.1007\/s00417-015-2950-1"},{"key":"55062","doi-asserted-by":"crossref","unstructured":"Wang H, Yan K, Wang R. Antibody heavy chain CDR3 length-dependent usage of human IGHJ4 and IGHJ6 germline genes. Antib Ther. 2021; 4(2):101-108.","DOI":"10.1093\/abt\/tbab010"},{"key":"55063","doi-asserted-by":"crossref","unstructured":"Forsgren A, Grubb AO. Many bacterial species bind human IgD. J Immunol. 1979; 122(4):1468-1472.","DOI":"10.4049\/jimmunol.122.4.1468"},{"key":"55064","doi-asserted-by":"crossref","unstructured":"Perez Vidakovics ML, Riesbeck K. Virulence mechanisms of Moraxella in the pathogenesis of infection. Curr Opin Infect Dis. 2009; 22(3):279-285.","DOI":"10.1097\/QCO.0b013e3283298e4e"},{"key":"55065","doi-asserted-by":"crossref","unstructured":"Samuelsson M, Jendholm J, Amisten S, Morrison SL, Forsgren A, Riesbeck K. The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID. Eur J Immunol. 2006; 36(9):2525-2534.","DOI":"10.1002\/eji.200535594"},{"key":"55066","doi-asserted-by":"crossref","unstructured":"Zucca E, Arcaini L, Buske C. Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020; 31(1):17-29.","DOI":"10.1016\/j.annonc.2019.10.010"},{"key":"55067","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991; 338(8776):1175-1176.","DOI":"10.1016\/0140-6736(91)92035-Z"},{"key":"55068","doi-asserted-by":"crossref","unstructured":"Wotherspoon AC, Doglioni C, Diss TC. Regression of primary low-grade B-cell gastric lymphoma of mucosaassociated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993; 342(8871):575-577.","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"55069","doi-asserted-by":"crossref","unstructured":"Chanudet E, Zhou Y, Bacon CM. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J Pathol. 2006; 209(3):344-351.","DOI":"10.1002\/path.1984"},{"key":"55070","doi-asserted-by":"crossref","unstructured":"Ferreri AJM, Govi S, Pasini E. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012; 30(24):2988-2994.","DOI":"10.1200\/JCO.2011.41.4466"},{"key":"55071","doi-asserted-by":"crossref","unstructured":"Borchmann S, Joffe E, Moskowitz CH. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood. 2019; 133(20):2121-2129.","DOI":"10.1182\/blood-2018-10-877761"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.282698\/75608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.282698\/76323","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11074\/75608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:02Z","timestamp":1794045842000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.282698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,4]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.282698","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,4]]}}}